Continuous epicapsular ropivacaine 0.3% infusion after minimally invasive hip arthroplasty: a prospective, randomized, double-blinded, placebo-controlled study comparing continuous wound infusion with morphine patient-controlled analgesia.

@article{Aguirre2012ContinuousER,
  title={Continuous epicapsular ropivacaine 0.3% infusion after minimally invasive hip arthroplasty: a prospective, randomized, double-blinded, placebo-controlled study comparing continuous wound infusion with morphine patient-controlled analgesia.},
  author={Jose A Aguirre and Barbara Baulig and Claudio Dora and Georgios Ekatodramis and Gina Votta-Velis and Philipp Ruland and Alain Borgeat},
  journal={Anesthesia and analgesia},
  year={2012},
  volume={114 2},
  pages={456-61}
}
BACKGROUND In this study, we investigated the impact of a continuous wound infusion with ropivacaine 0.3% on pain and morphine consumption after minimally invasive hip arthroplasty. METHODS Seventy-six consecutive patients scheduled for elective minimally invasive hip replacement using spinal anesthesia were prospectively included in this double-blind study. Epicapsular placement of a 15-cm fenestrated catheter was performed by the surgeon. Patients were randomized to receive either 20 mL… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Local infiltration analgesia for postoperative pain after hip arthroplasty: a systematic review and meta-analysis.

The journal of pain : official journal of the American Pain Society • 2014
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…